Background: This study evaluates the efficacy of lingual tonsil resection by transoral robotic surgery (TORS) in a large group of patients with recurrent lingual tonsilli- tis (RLT). Methods: Eighty-four patients with RLT treated with a lingual tonsil surgical re- section using TORS were analyzed in terms of their postoperative results, disease recurrence, postoperative dysphagia, and quality of life. Results: A reduction of the mean number/year of acute lingual tonsillitis (LT) episodes emerged after surgery (5.17 vs 0.54 events), comparing the mean num- ber of preoperative and postoperative LT episodes, a statistical significance emerged (P = .0001). The postoperative endoscopic evaluation showed 94.1% of patients with absent or poor lymphatic tissue on the tongue base. Evaluation of postoperative dys- phagia showed good results with an average score of 85.9 ± 7.5. Conclusion: This article explains how in patients with chronic LT with medical ther- apy failure and impaired quality of life, TORS could represent a valid therapeutic option.
Use of the transoral robotic surgery to treat patients with recurrent lingual tonsillitis
Antonino Maniaci;
2020-01-01
Abstract
Background: This study evaluates the efficacy of lingual tonsil resection by transoral robotic surgery (TORS) in a large group of patients with recurrent lingual tonsilli- tis (RLT). Methods: Eighty-four patients with RLT treated with a lingual tonsil surgical re- section using TORS were analyzed in terms of their postoperative results, disease recurrence, postoperative dysphagia, and quality of life. Results: A reduction of the mean number/year of acute lingual tonsillitis (LT) episodes emerged after surgery (5.17 vs 0.54 events), comparing the mean num- ber of preoperative and postoperative LT episodes, a statistical significance emerged (P = .0001). The postoperative endoscopic evaluation showed 94.1% of patients with absent or poor lymphatic tissue on the tongue base. Evaluation of postoperative dys- phagia showed good results with an average score of 85.9 ± 7.5. Conclusion: This article explains how in patients with chronic LT with medical ther- apy failure and impaired quality of life, TORS could represent a valid therapeutic option.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.